Mastura Monif

99 Commercial Rd
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 133 publications

Response to the commentary on - Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.

Response to the commentary on - Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.

Journal: Journal of the neurological sciences

Published: July 31, 2026

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors.

Australian consensus recommendations for the management of increased meningococcal infection risk in adults with neurological diseases treated with complement inhibitors.

Journal: Internal medicine journal

Published: May 28, 2026

Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.

Rituximab in Myasthenia Gravis: a real-world study using inverse probability of treatment weighting.

Journal: Frontiers in neurology

Published: May 16, 2026

Modern diagnosis and treatment of multiple sclerosis: advances, challenges, and future directions.

Modern diagnosis and treatment of multiple sclerosis: advances, challenges, and future directions.

Journal: Autoimmunity reviews

Published: May 11, 2026

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: April 28, 2026

The Imbalance Between Tumor Immunosurveillance and Tumor Immune Escape in Glioblastoma.

The Imbalance Between Tumor Immunosurveillance and Tumor Immune Escape in Glioblastoma.

Journal: Immunology and cell biology

Published: March 23, 2026

Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology

Published: March 05, 2026

Plasma proteome in LGI-1 autoimmune encephalitis.

Plasma proteome in LGI-1 autoimmune encephalitis.

Journal: Journal of neuroinflammation

Published: February 23, 2026

A Critical Review of Clinical Factors and Tools for Predicting Chimeric Antigen Receptor T-Cell Toxicities.

A Critical Review of Clinical Factors and Tools for Predicting Chimeric Antigen Receptor T-Cell Toxicities.

Journal: Transplantation and cellular therapy

Published: February 22, 2026

Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.

Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission.

Journal: Journal of the neurological sciences

Published: February 05, 2026

Inter-attack serum GFAP and NfL remain stable over 9 years in AQP4 IgG NMOSD.

Inter-attack serum GFAP and NfL remain stable over 9 years in AQP4 IgG NMOSD.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: January 21, 2026

Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosis.

Cross-sectional brain volumetric measures and disability outcomes in relapsing-remitting multiple sclerosis.

Journal: Journal of neurology

Published: January 11, 2026

Showing 1-12 of 133

Last Updated: 09/26/2026